Low utilization of GLP-1RAs and SGLT2i in high-risk cardiovascular patients with diabetes: nationwide insights from myocardial Infarction and stroke survivors

Back

ESC Professional Premium Access

Low utilization of GLP-1RAs and SGLT2i in high-risk cardiovascular patients with diabetes: nationwide insights from myocardial Infarction and stroke survivors

Session: New perspectives in cardiology (4) - Secondary prevention

Topic: Secondary Prevention

Speaker: Professor M. Vrablik (Prague, CZ)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Michal Vrablik

Charles University of Prague, Prague (Czechia)

5 presentations

1 follower

10 more presentations in this session

Discussant - Secondary prevention

Access

Trajectories of adherence to secondary prevention pharmacotherapy after coronary angiography: a retrospective population-based study

Speaker: Doctor L. Heitmann (Reykjavik, IS)

Evaluation of diagnostic accuracy of extreme cardiovascular risk definitions in acute coronary syndrome patients

Speaker: Doctor A. Maloberti (Milan, IT)

CVDPREVENT- the national audit of cardiovascular disease prevention in primary care in England driving quality improvement

Speaker: Mrs L. Corteville (Manchester, GB)

GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany

Speaker: Doctor V. Oettinger (Freiburg, DE)

Access

Abstract

Access the full session

New perspectives in cardiology (4) - Secondary prevention

Speakers: Professor M. Vrablik, Doctor L. Heitmann, Doctor A. Maloberti, Mrs L. Corteville, Doctor V. Oettinger

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources